Results of the c-TRAK TN trial: a clinical trial utilising ctDNA mutation tracking to detect molecular residual disease and trigger intervention in patients with moderate- and high-risk early-stage triple-negative breast cancer.
Saved in:
| Title: | Results of the c-TRAK TN trial: a clinical trial utilising ctDNA mutation tracking to detect molecular residual disease and trigger intervention in patients with moderate- and high-risk early-stage triple-negative breast cancer. |
|---|---|
| Authors: | Turner, N.C.1,2 (AUTHOR) Nick.Turner@icr.ac.uk, Swift, C.3,4 (AUTHOR), Jenkins, B.5 (AUTHOR), Kilburn, L.5 (AUTHOR), Coakley, M.3,4 (AUTHOR), Beaney, M.3 (AUTHOR), Fox, L.5 (AUTHOR), Goddard, K.5 (AUTHOR), Garcia-Murillas, I.3 (AUTHOR), Proszek, P.6 (AUTHOR), Hall, P.7 (AUTHOR), Harper-Wynne, C.8 (AUTHOR), Hickish, T.9 (AUTHOR), Kernaghan, S.5 (AUTHOR), Macpherson, I.R.10 (AUTHOR), Okines, A.F.C.2 (AUTHOR), Palmieri, C.11 (AUTHOR), Perry, S.5 (AUTHOR), Randle, K.12 (AUTHOR), Snowdon, C.5 (AUTHOR) |
| Source: | Annals of Oncology. Feb2023, Vol. 34 Issue 2, p200-211. 12p. |
| Database: | Academic Search Ultimate |
| ISSN: | 09237534 |
|---|---|
| DOI: | 10.1016/j.annonc.2022.11.005 |
